These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 32092817

  • 1. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
    Hua B, Li Y, Yang X, Niu X, Zhao Y, Zhu X.
    Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
    [Abstract] [Full Text] [Related]

  • 2. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL, Tobiasen H, Holm A, Schepeler T, Ostenfeld MS, Thorsen K, Rasmussen MH, Birkenkamp-Demtroeder K, Sieber OM, Gibbs P, Lubinski J, Lamy P, COLOFOL steering group, Laurberg S, Oster B, Hansen KQ, Hagemann-Madsen R, Byskov K, Ørntoft TF, Andersen CL.
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [Abstract] [Full Text] [Related]

  • 3. Kinetic modeling-based detection of genetic signatures that provide chemoresistance via the E2F1-p73/DNp73-miR-205 network.
    Vera J, Schmitz U, Lai X, Engelmann D, Khan FM, Wolkenhauer O, Pützer BM.
    Cancer Res; 2013 Jun 15; 73(12):3511-24. PubMed ID: 23447575
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z, Nourbakhsh M, Hosseinkhani S, Hesari Z, Alipour M, Jafarzadeh M, Ghorbanhosseini SS, Seiri P, Yousefi Z, Yarahmadi S, Golpour P.
    J Cell Biochem; 2019 Jun 15; 120(6):9356-9368. PubMed ID: 30520099
    [Abstract] [Full Text] [Related]

  • 5. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
    Zheng Y, Zheng Y, Lei W, Xiang L, Chen M.
    Mol Cell Probes; 2019 Dec 15; 48():101445. PubMed ID: 31513891
    [Abstract] [Full Text] [Related]

  • 6. Aspongopus chinensis ach-miR-276a-3p induces breast cancer cell cycle arrest by targeting APPL2 to regulate the CDK2-Rb-E2F1 signaling pathway.
    Cai R, Khan S, Chen X, Li H, Tan J, Tian Y, Zhao S, Yin Z, Liu T, Jin D, Guo J.
    Toxicol Appl Pharmacol; 2024 Mar 15; 484():116877. PubMed ID: 38431228
    [Abstract] [Full Text] [Related]

  • 7. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
    Sang XB, Zong ZH, Wang LL, Wu DD, Chen S, Liu BL, Zhao Y.
    Oncotarget; 2017 Feb 28; 8(9):14777-14793. PubMed ID: 28146423
    [Abstract] [Full Text] [Related]

  • 8. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T, Song Y, Yu H, Luo X.
    Cancer Biol Ther; 2019 Feb 28; 20(6):760-773. PubMed ID: 30810442
    [Abstract] [Full Text] [Related]

  • 9. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V, Kowtharapu BS, Engelmann D, Emmrich S, Schmitz U, Steder M, Pützer BM.
    Cell Cycle; 2012 Aug 15; 11(16):3067-78. PubMed ID: 22871739
    [Abstract] [Full Text] [Related]

  • 10. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G, Liu K, Du X.
    Yonsei Med J; 2018 Mar 15; 59(2):226-235. PubMed ID: 29436190
    [Abstract] [Full Text] [Related]

  • 11. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M, Zhang M, Tao Z, Cao J, Wang L, Hu X.
    Technol Cancer Res Treat; 2020 Mar 15; 19():1533033820905824. PubMed ID: 32174262
    [Abstract] [Full Text] [Related]

  • 12. Transcription factor p53-mediated activation of miR-519d-3p and downregulation of E2F1 attenuates prostate cancer growth and metastasis.
    Zhang D, Yang XJ, Luo QD, Xue L, Chong T.
    Cancer Gene Ther; 2022 Jul 15; 29(7):1001-1011. PubMed ID: 34799723
    [Abstract] [Full Text] [Related]

  • 13. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP, Mou ZL, Xu YY, Liu GX, Wang DM, Zhang HP.
    Eur Rev Med Pharmacol Sci; 2019 Sep 15; 23(17):7445-7456. PubMed ID: 31539132
    [Abstract] [Full Text] [Related]

  • 14. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B, Chen D, Zhou Q, Hang J, Zhang W, Kuang Z, Sun Z, Li L.
    BMC Cancer; 2019 Sep 06; 19(1):891. PubMed ID: 31492116
    [Abstract] [Full Text] [Related]

  • 15. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
    Zhao X.
    Biomed Res Int; 2020 Sep 06; 2020():1480819. PubMed ID: 32733928
    [Abstract] [Full Text] [Related]

  • 16. miRNA-329-3p suppresses proliferation and metastasis of endometrial carcinoma through downregulating E2F1.
    Wang R, Zhang C, Guan W, Yang Q.
    Neoplasma; 2023 Aug 06; 70(4):566-579. PubMed ID: 37789781
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
    Xia XY, Yu YJ, Ye F, Peng GY, Li YJ, Zhou XM.
    Neoplasma; 2020 Mar 06; 67(2):344-353. PubMed ID: 31973537
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z, Li Y, Xu J, Ren Q, Yao J, Tian X.
    IUBMB Life; 2016 May 06; 68(5):394-402. PubMed ID: 27079864
    [Abstract] [Full Text] [Related]

  • 19. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma.
    Zhao L, Zheng Y, Zhang L, Su L.
    Cancer Biother Radiopharm; 2022 May 06; 37(4):276-286. PubMed ID: 33571038
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
    Li S, Xu JJ, Zhang QY.
    Cancer Sci; 2019 Oct 06; 110(10):3098-3109. PubMed ID: 31389121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.